Jim Cramer's Charitable Trust is selling its remaining 120 Broadcom (AVGO) shares at roughly $326 each, exiting the position with an average gain of roughly 128% on shares bought in 2023 and 2024. It is also selling 85 CrowdStrike (CRWD) shares at roughly $251, cutting its weighting to 4.25% from 4.8% after a big move, for a gain of roughly 187% on shares bought in late 2024. The trust says the moves reflect a more defensive approach amid a struggling data center theme over funding concerns, with fewer holdings until the pending Anthropic IPO, expected as soon as mid-November, plays out and Meta Platforms' future equity raises become clearer. Cramer said the approach means 'circling the wagons,' with bigger positions in the better names, and that the Broadcom sale protects large gains and limits exposure to a group under fire.
Summary written by Upside AI from the original article. Read the source for full details.
Keywords
Broadcomsemiconductorsdata centersinvestment trusts
Open a keyword to see other news on the same topic.
Related tickers and likely impact
NVDA
• NeutralNvidia
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Information Technology |
| Industry | Semiconductors |
| Market cap | $5.2T |
| Close on 10/22/2026 | 212.28 |
| Change that session | -4.36% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- 3 Magnificent AI Chip Stocks That Could Help Set You Up for Life
The article argues the semiconductor industry can build long-term wealth, with global chip sales projected to rise from $126 billion in 1998 to $1.6 trillion in 2026, according to the Semiconductor Industry Association. It highlights three stocks: Nvidia, Broadcom and Cerebras Systems. Nvidia is up about 19% over the past year, with fiscal Q2 2026 revenue more than doubling year over year, a 64% profit margin and a valuation of about 14 times next year's expected earnings. Broadcom's AI chip revenue nearly tripled to almost $17 billion in its fiscal third quarter, while its stock is down about 3% over the past year as of Oct. 20. Cerebras trades about 32% below its IPO price despite 75% revenue growth in 2025, and the article calls it the riskiest of the three because it is still losing money.
- AMD or Broadcom: If I Could Only Own 1 AI Chip Stock Through 2030, Here's My Pick
AMD and Broadcom have both benefited from the AI boom, with AMD shares up 421% and Broadcom up 285% over three years. In Q2, AMD's revenue rose 50% year over year to $11.5 billion, its data center segment reached $6.7 billion (up 107%), and non-GAAP EPS hit $1.66 (up 246%), with AMD projecting a $220 billion CPU opportunity and a $1.4 trillion AI accelerator opportunity by 2030. Broadcom's fiscal Q3 2026 revenue grew 86% to $29.6 billion, with AI semiconductor revenue up 221% to $16.7 billion, and it projects $115 billion in AI revenue for fiscal 2027 and $230 billion for fiscal 2028. The author gives a slight edge to Broadcom on valuation, at 19.4x forward earnings versus 39.5x for AMD, though AMD's EPS is growing faster. Broadcom's margins could decline as lower-margin AI chip sales take a larger share of its total revenue.
- Same Playbook, Different Silicon: Broadcom Holds the Throne, Marvell Plays the AMD Challenger.
Broadcom and Marvell both beat AI estimates and raised guidance, but Broadcom operates at much larger scale, with AI semiconductor revenue of $16.70 billion, up 221% year over year and 56% of total revenue. Custom XPUs supplied 73% of its AI revenue, while gross margin slipped to 75% and operating margin reached 67.9%. Marvell reported $2.74 billion in revenue, up 36.5%, with data center sales at 79% of the total, and its Google deal includes a warrant for up to 7% of its shares. Broadcom guided to Q4 revenue of about $34.8 billion and AI revenue of about $21.7 billion, while Marvell guided to $3.15 billion and plans about $1 billion in supplier prepayments. Marvell is up 163.4% year to date, while Broadcom is down 6.09%.
- Broadcom Stock Fell 4% as Chip Stocks Slid Days After a 10-Year VMware Deal. Here’s What Wall Street’s Targets Say
Broadcom fell 4.31% to $323.24 on October 22 as chip stocks slid on renewed worries about AI spending, three days after it signed NTT DOCOMO to a 10-year VMware agreement. Shares were about 33% below their June closing high, while the next-twelve-month EPS estimate rose 68% from $10.30 on February 1 to $17.34 on October 21, cutting the forward P/E from about 32 times to about 19 times. Infrastructure software, built mostly on VMware, added $8,752 million in fiscal Q3, up 29%, and earned about 77% segment operating margin in fiscal 2025 versus about 58% for semiconductors. The mean Street target of about $528 sits roughly 63% above the October 22 close, and 47 of 52 ratings are Buy or Outperform.
- Prediction: Broadcom Stock Could Crush the S&P 500 Through 2030
Broadcom's AI revenue is surging, with fiscal Q3 revenue of $29.59 billion (up 85.5% year over year) and AI semiconductor revenue of $16.70 billion, yet the stock is down 2.41% year to date while the S&P 500 is up 12.87%. Q3 gross margin fell 210 basis points sequentially to 75%, with Q4 guided to about 73% as memory-heavy XPUs dilute the mix, and customer concentration is another risk. The consensus target of $527.59 implies 57.4% upside from $335.18, while the article's base case is $410.50, or 22.47% upside. Reaching $700 requires a 108.8% gain, or about 38x forward EPS of $18.376; the article calls this a stretch but achievable if AI revenue meets the fiscal 2027 outlook and EPS clears $30 in fiscal 2028. The main risks are supply shortages of wafers, HBM, power or data center capacity, and a sharp pullback in hyperscaler spending.
- Has Buying Broadcom Stock's Dips Paid Off?
Broadcom (AVGO) shares fell 11.2% from their October 7, 2026 high to the October 20 close, with the steepest drop of 4.5% on October 16. Since 2010, Broadcom has had nine falls of over 20% within about six weeks; seven of them are more than a year old, and the shares were higher a year later in every case, with a median gain of 45%. Fiscal Q3 2026 revenue reached $29.6 billion, up 85.5%, with AI semiconductor revenue up 221% and operating margin at 54.3%. At the October 20 close, Broadcom traded at 41.6 times last twelve months' earnings, versus 23.0 for the S&P 500. Management expects fiscal Q4 2026 revenue of $34.8 billion, with results expected around December 9, 2026.
Related markets
Latest news
- XRP News: Ripple Joined DTCC’s Tokenization Push This Week. Can It Pull XRP Out of Its October Slide?
Ripple Prime, Ripple's prime brokerage division, is part of the DTCC-led tokenization working group alongside BlackRock, JPMorgan and about 50 other firms. Yet XRP has shown little reaction, trading at $1.31, down 12.1% in October and below its 20-day ($1.37) and 50-day ($1.41) averages. DTCC's first production trades on July 15, 2026, ran on Besu and Canton without Ripple Prime, and DTCC has not confirmed any involvement by XRP or the XRP Ledger. The settlement asset was not specified, so settlements could involve bank deposits, Circle's USDC or Ripple's RLUSD. XRP's link to Ripple Prime runs mainly through collateral, which clients can post alongside RLUSD and other assets.
- Crypto Scammers Who Used Prayer Groups to Lure Victims Must Pay $1.3 Billion, Says New York
New York Attorney General Letitia James is asking a court to order NovaTech founders Cynthia and Eddy Petion, and related companies, to pay about $1.37 billion after the couple fled the U.S. and failed to respond to the state's lawsuit. Four top promoters agreed to pay nearly $6 million to benefit victims and are permanently barred from the securities, commodities and crypto industries. The state says the scheme targeted immigrant communities, particularly Haitian New Yorkers, through prayer groups, social media and WhatsApp, drawing more than 11,000 New Yorkers with advertised returns of 2% to 4% a week. In reality, NovaTech sent just under $26 million to its trading provider and lost about $18.2 million, while weekly payouts came from new investors' deposits. When NovaTech collapsed in 2023, tens of thousands of investors could not withdraw their funds.
- Doctors call Moderna, Merck cancer vaccine data a major advancement — despite Wall Street reaction
Six melanoma specialists told CNBC that Phase 3 results for Moderna and Merck's personalized cancer vaccine, intismeran autogene, given with Keytruda represent a clinically meaningful advance. The combination reduced the risk of melanoma recurrence or death by 42% and the risk of distant spread or death by 38% compared with Keytruda alone, in a trial of roughly 1,100 patients whose tumors were surgically removed. Doctors said it could eventually become a standard of care for patients who have surgery first and have not received immunotherapy beforehand, though questions remain about survival benefit and which patients benefit most. Moderna shares fell as much as 25% on Thursday after partial data leaked on social media, even though the stock is up nearly 600% this year on optimism about the cancer shot. Moderna is finishing a regulatory filing and aims to get the drug fully approved next year.
- Palantir Guided for $2.16 Billion in Revenue for Q3. Its Last 2 Quarters Suggest We Should Expect More.
Palantir (PLTR) guided for third-quarter revenue of $2.160 billion to $2.164 billion, but the author considers that forecast conservative given its first-half results. In the first and second quarters, revenue beat the midpoint of guidance by about 6.4% and 7.5%, with second-quarter revenue reaching $1.935 billion, up 93% year over year. U.S. commercial revenue rose 149% to $764 million in the second quarter, and total contract value reached $3.37 billion. If sequential growth matches the 19% of the second quarter, third-quarter revenue would be about $2.3 billion, and the author will be watching whether it exceeds that level.
- What we want to see when this data center stock reports earnings next week
Stocks mostly fell on Friday, with the Dow down about 1% as selling spread beyond the AI trade, and West Texas Intermediate crude rose above $103 per barrel on renewed US-Iran tensions. Palo Alto Networks and CrowdStrike were the Investing Club's best performers, each up more than 6%, while the Club exited Broadcom. Meta shares fell again, extending Thursday's nearly 7% decline, as investors questioned how its AI buildout will be funded after free cash flow turned negative for the first time since its 2012 IPO. The Club is sticking with Meta given its strong fundamentals and Muse roadmap, and it added a few shares of GE Vernova during Thursday's sell-off. Ahead of GE Vernova's earnings next week, the Club wants to see continued strong orders for heavy-duty gas turbines and strong pricing.
- SpaceX earnings, tech sell-off lead to rocky week for investors
SpaceX beat estimates in its Q3 report and Elon Musk openly backed a merger with Tesla, sending shares up 9% on Wednesday, but a tech sell-off erased the gain on Thursday. Connectivity revenue, mostly from Starlink, rose 69% to $5.2 billion, and Starlink added 1.6 million subscribers, bringing the total to just under 14 million broadband consumer subscribers. Bloomberg reported SpaceX is looking to lease space on 80,000 US cell sites and is in talks with Crown Castle and American Tower. Both companies have formed special committees to explore a combination worth about $3.5 trillion, which needs approval from 50% of Tesla shareholders, while Reuters reported Musk's endorsement could delay the process by weeks. Shares are up 1% for the week, and Thursday's slide also came as about 911.5 million insider shares became eligible for sale.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.